Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Methylphenidate 40mg MR chew tab sugar free
0404000M0AABFBF
|
Methylphenidate hydrochloride | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Methylphenidate 6.25mg/5ml oral solution
0404000M0AAADAD
|
Methylphenidate hydrochloride | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Methylprednisolone 1mg/5ml oral suspension
0603020S0AAAEAE
|
Methylprednisolone | Methylprednisolone | Endocrine System | No data available |
|
Methylprednisolone sodium succinate 1g inj vials
0603020K0AAADAD
|
Methylprednisolone sodium succinate | Methylprednisolone sodium succinate | Endocrine System | No data available |
|
Methylprednisolone sodium succinate 2g inj vials
0603020K0AAAEAE
|
Methylprednisolone sodium succinate | Methylprednisolone sodium succinate | Endocrine System | No data available |
|
Methyltestosterone 10mg capsules
0604020H0AAAJAJ
|
Methyltestosterone | Methyltestosterone | Endocrine System | No data available |
|
Methysergide 1mg tablets
0407042L0AAAAAA
|
Methysergide | Methysergide | Central Nervous System | No data available |
|
Metipranolol 0.1% eye dps 0.5ml unit dose preservative free
1106000U0AAADAD
|
Metipranolol | Metipranolol | Eye | No data available |
|
Metipranolol 0.3% eye dps 0.5ml unit dose preservative free
1106000U0AAAEAE
|
Metipranolol | Metipranolol | Eye | No data available |
|
Metoclomex 10mg tablets
0406000P0BMAAAE
|
Metoclomex | Metoclopramide hydrochloride | Central Nervous System | No data available |
|
Metoclopramide 15mg modified-release capsules
0406000P0AAAJAJ
|
Metoclopramide hydrochloride | Metoclopramide hydrochloride | Central Nervous System | No data available |
|
Metoclopramide 15mg modified-release tablets
0406000P0AAAHAH
|
Metoclopramide hydrochloride | Metoclopramide hydrochloride | Central Nervous System | No data available |
|
Metoject 10mg/1ml solution for injection pre-filled syringes
1001030U0BEACBB
|
Metoject (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Metoject 12.5mg/0.25ml inj pre-filled syringes
1001030U0BEALBK
|
Metoject (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Metoject 15mg/1.5ml inj pre-filled syringes
1001030U0BEADBC
|
Metoject (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Metoject 20mg/2ml solution for injection pre-filled syringes
1001030U0BEABBA
|
Metoject (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Metoject 22.5mg/0.45ml inj pre-filled syringes
1001030U0BEANBM
|
Metoject (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Metoject 25mg/2.5ml inj pre-filled syringes
1001030U0BEAEBD
|
Metoject (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Metoject 27.5mg/0.55ml inj pre-filled syringes
1001030U0BEAPBN
|
Metoject (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Metoject 30mg/0.6ml inj pre-filled syringes
1001030U0BEAKBJ
|
Metoject (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Metoject 7.5mg/0.15ml inj pre-filled syringes
1001030U0BEAFBE
|
Metoject (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Metoject 7.5mg/0.75ml inj pre-filled syringes
1001030U0BEAAAZ
|
Metoject (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Metolazone 1.25mg/5ml oral liquid
0202010V0AAAMAM
|
Metolazone | Metolazone | Cardiovascular System | No data available |
|
Metolazone 1mg/5ml oral liquid
0202010V0AAAFAF
|
Metolazone | Metolazone | Cardiovascular System | No data available |
|
Metolazone 500micrograms/5ml oral liquid
0202010V0AAAJAJ
|
Metolazone | Metolazone | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.